{
  "id": "adv_mhgap#management_302295e6",
  "content": "144\nAnnex 2.\nManaging declarations of\ninterest and conflicts\nof interest\nAll contributors declared no interests, with the exception of those listed below. A summary of declared interests and\nhow they were managed is provided below.\nDeclared interests of the members of the Guideline Development Group (GDG)\nName and title Declaration of interest Conflict of interest and management\nDr Amza Ali Employed and holds stocks, shares and a The Psyence group is a biotechnology\ncommercial interest in Psyence Group. company developing psychedelic\ntherapies. The nature of the company\nwas not considered to represent a\nconflict as psychedelic therapy is\nnot included anywhere in mhGAP\nand was not a part of any of the PICO\nquestion discussions. No conflict of\ninterest identified.\nProfessor Sawitri None No conflict of interest identified.\nAssanangkornchai\nProfessor Henry Brodaty Employed by the University of New South No conflict of interest identified.\nWales, Sydney. Payment for consultancy\nor advisory board membership for Biogen\nPharmaceuticals, Cranbrook Care, Nutricia\nAustralia, Roche, Skin2Neuron. Ongoing\nresearch support from Australia’s National\nHealth Medical Research Council (NHMRC)\nand the Commonwealth Department\nof Health (Australian Government).\nHonorary Advisor to Alzheimer’s Disease\nInternational, Dementia Australia and\nMontefiore Homes, Sydney.\n145",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Management 144\nAnnex 2.\nManaging declarations of\ninterest and conflicts\nof interest\nAll contributors declared no interests, with the exception of those listed below. A summary of declared interests and\nhow they were managed is provided below.\nDeclared interests of the members of the Guideline Development Group (GDG)\nName and title Declaration of interest Conflict of interest and management\nDr Amza Ali Employed and holds stocks, shares and a The Psyence group is a biotechnology\ncommercial interest in Psyence Group. company developing psychedelic\ntherapies. The nature of the company\nwas not considered to represent a\nconflict as psychedelic therapy is\nnot included anywhere in mhGAP\nand was not a part of any of the PICO\nquestion discussions. No conflict of\ninterest identified.\nProfessor Sawitri None No conflict of interest identified.\nAssanangkornchai\nProfessor Henry Brodaty Employed by the University of New South No conflict of interest identified.\nWales, Sydney. Payment for consultancy\nor advisory board membership for Biogen\nPharmaceuticals, Cranbrook Care, Nutricia\nAustralia, Roche, Skin2Neuron. Ongoing\nresearch support from Australia’s National\nHealth Medical Research Council (NHMRC)\nand the Commonwealth Department\nof Health (Australian Government).\nHonorary Advisor to Alzheimer’s Disease\nInternational, Dementia Australia and\nMontefiore Homes, Sydney.\n145 144\nannex 2. managing declarations of\ninterest and conflicts\nof interest\nall contributors declared no interests, with the exception of those listed below."
}